Comparing Different Eating Plans for Long-Term Weight Management in People With Overweight or Obesity
Compares individualized eating plans with a standard calorie-restricted diet in adults with overweight.
Plain-language title generated from the registry record
Registry title: Efficacy of Different Dietary Pattern in Long-term Weight Management
Key facts
- Where
- Shanghai, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 59 years old?
Source: NCT07773558, who can take part
Where in China
- Ruijin Hospital Shanghai Jiaotong University School of MedicineShanghai, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Guang Ning
- Trial code
- NCT07773558
- Record updated
- 19 August 2026
- Original description
This study is a nationwide multi-center, long-term randomized controlled clinical trial, aiming to evaluate the effects of individualized dietary pattern management programs compared to traditional energy-restricted diets in weight management.Read full original descriptionShow less
A Multicenter Randomized Controlled Trial Evaluating the Efficacy of Different Dietary Pattern Management Programs in Long-term Weight Management
This study is a nationwide multi-center, long-term randomized controlled clinical trial, aiming to evaluate the effects of individualized dietary pattern management programs compared to traditional energy-restricted diets in weight management.
Inclusion: Male or female, aged 20-59 years; Obesity defined by BMI≥28 kg/m²; With willingness to undergo dietary intervention for weight loss.
Exclusion: Suffering from gastrointestinal diseases that affect food digestion and absorption (such as functional bowel disorders, etc.), or having a known history of food allergies, or having a history of previous gastrointestinal surgery that affects dietary intervention; Currently participating in another interventional study or having participated in another drug clinical trial within the past 3 months; Having been diagnosed with clinical cardiovascular disease (coronary heart disease, stroke, heart failure, etc.) or malignancy; Any condition deemed by the investigator to affect study compliance; Suffering from diseases that affect body weight or glucose and lipid metabolism (such as uncontrolled hyponatremia, thyroid dysfunction, secondary hypertension, type 1 diabetes, Cushing's syndrome, etc.); Currently undergoing pharmacological treatment that affects body weight or glucose and lipid metabolism (such as thyroid medications, corticosteroids, antidiabetic drugs, lipid-lowering drugs, diuretics, etc.); Suffering from severe liver or kidney disease (alanine aminotransferase or serum creatinine levels exceeding 2 times the upper limit of normal); BMI≥40 kg/m²; Pregnant, breastfeeding, or women of childbearing potential who are not using contraception.